LAFARGEHOLCIM Earnings Calls
| Release date | Feb 27, 2026 |
| EPS estimate | $2.38 |
| EPS actual | $2.07 |
| EPS Surprise | -13.03% |
| Revenue estimate | 9.918B |
| Revenue actual | 9.907B |
| Revenue Surprise | -0.113% |
| Release date | Feb 27, 2026 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Jul 29, 2025 |
| EPS estimate | - |
| EPS actual | $15.59 |
| Revenue estimate | 16.933B |
| Revenue actual | 4.953B |
| Revenue Surprise | -70.75% |
| Release date | Apr 24, 2025 |
| EPS estimate | - |
| EPS actual | $14.54 |
| Revenue estimate | - |
| Revenue actual | 4.621B |
Last 4 Quarters for LAFARGEHOLCIM
Below you can see how HCMLF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Apr 24, 2025 |
| Price on release | $107.88 |
| EPS estimate | - |
| EPS actual | $14.54 |
| Date | Price |
|---|---|
| Apr 17, 2025 | $106.00 |
| Apr 21, 2025 | $106.00 |
| Apr 22, 2025 | $106.00 |
| Apr 23, 2025 | $107.88 |
| Apr 24, 2025 | $107.88 |
| Apr 25, 2025 | $111.76 |
| Apr 28, 2025 | $111.76 |
| Apr 29, 2025 | $107.90 |
| Apr 30, 2025 | $107.90 |
| 4 days before | 1.77% |
| 4 days after | 0.0185% |
| On release day | 0% |
| Change in period | 1.79% |
| Release date | Jul 29, 2025 |
| Price on release | $80.75 |
| EPS estimate | - |
| EPS actual | $15.59 |
| Date | Price |
|---|---|
| Jul 23, 2025 | $81.00 |
| Jul 24, 2025 | $81.00 |
| Jul 25, 2025 | $80.89 |
| Jul 28, 2025 | $80.75 |
| Jul 29, 2025 | $80.75 |
| Jul 30, 2025 | $80.75 |
| Jul 31, 2025 | $78.70 |
| Aug 01, 2025 | $78.31 |
| Aug 04, 2025 | $78.31 |
| 4 days before | -0.309% |
| 4 days after | -3.02% |
| On release day | 0% |
| Change in period | -3.32% |
| Release date | Feb 27, 2026 |
| Price on release | $91.47 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Feb 23, 2026 | $91.35 |
| Feb 24, 2026 | $91.35 |
| Feb 25, 2026 | $91.35 |
| Feb 26, 2026 | $91.69 |
| Feb 27, 2026 | $91.47 |
| Mar 02, 2026 | $87.09 |
| Mar 03, 2026 | $87.09 |
| Mar 04, 2026 | $87.09 |
| Mar 05, 2026 | $87.20 |
| 4 days before | 0.131% |
| 4 days after | -4.67% |
| On release day | -4.79% |
| Change in period | -4.54% |
| Release date | Feb 27, 2026 |
| Price on release | $91.47 |
| EPS estimate | $2.38 |
| EPS actual | $2.07 |
| EPS surprise | -13.03% |
| Date | Price |
|---|---|
| Feb 23, 2026 | $91.35 |
| Feb 24, 2026 | $91.35 |
| Feb 25, 2026 | $91.35 |
| Feb 26, 2026 | $91.69 |
| Feb 27, 2026 | $91.47 |
| Mar 02, 2026 | $87.09 |
| Mar 03, 2026 | $87.09 |
| Mar 04, 2026 | $87.09 |
| Mar 05, 2026 | $87.20 |
| 4 days before | 0.131% |
| 4 days after | -4.67% |
| On release day | -4.79% |
| Change in period | -4.54% |
LAFARGEHOLCIM Earnings Call Transcript Summary of Q4 2025
Holcim delivered a strong 2025 with profitable growth, margin expansion and robust cash generation. Recurring EBIT grew 12.2% in Q4 and 10.3% for the year, recurring EBIT margin widened to 18.3%, and free cash flow was CHF 2.2bn with a 54% cash conversion. The Board proposed a CHF 1.70 dividend (≈53% payout; 2.4% post-tax yield). Management set 2026 guidance aligned with its NextGen Growth 2030 targets: organic net sales +3–5% and organic recurring EBIT +8–10%, continued margin progression and ~CHF 2bn cash flow. Regionally: Europe delivered continued margin expansion driven by a “high‑value” strategy (sustainable offerings, circular construction); LatAm showed double‑digit sales growth with >30% recurring EBIT margin despite integration costs; EMEA/Asia saw strong double‑digit EBIT growth led by North Africa and Australia. Key strategic themes: scaling premium low‑carbon brands (ECOPact, ECOPlanet), expanding circular construction hubs (109 hubs; CHF ~500m circular sales in 2025, target CHF 800m by 2030), disciplined, value‑accretive M&A (notable deals: Xella, Pacasmayo) and prioritized capital allocation. Holcim reiterates a conservative balance‑sheet approach (net leverage target <1.5x long term), capacity to deploy up to CHF 22bn to 2030 (including ~CHF 7bn returned to shareholders), and willingness to invest in decarbonization/CCUS projects while noting current ETS uncertainty has not altered near‑term plans. Management expects continued pricing discipline and sees limited immediate downside from EU ETS review, while emphasizing flexibility to delay or redesign CCUS projects if needed.
Sign In
Buy HCMLF